Zwitterionic Photosensitizer Triggers Photopyroptosis for Effective Cancer Immunotherapy
Advanced Healthcare Materials · 2026-03 · 15 (12)
DOI: 10.1002/adhm.202503451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.12.2025. Verfasst von Zhuofan Diao und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Engineering of Polymers and Department of Macromolecular Science, Fudan University, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Pyroptosis, Photochemotherapy, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Open Project of State Key Laboratory of Molecular Engineering of Polymers.
Abstract (Originalsprache)
Photopyroptosis, a lytic and immunogenic cell death modality triggered by photosensitizer (PS)‐generated reactive oxygen species under specific light irradiation, offers a promising strategy to overcome the inherent limitations of conventional cancer therapies. However, the precise design of PSs to induce photopyroptosis under hypoxic tumor microenvironments remains challenging. Herein, we report a zwitterionic nano‐photosensitizer (PCBMA‐TAPP) that combines mitochondrial‐targeted Type I photodynamic therapy (PDT) with enhanced tumor accumulation to potentiate pyroptosis‐driven immunotherapy. A comparative evaluation of three porphyrin‐based PSs identified tetra (4‐aminophenyl) porphyrin (TAPP) as a lead candidate with superior mitochondrial localization and enhanced generation of superoxide anions (•O 2 − ), enabling potent caspase‐3/gasdermin E‐mediated pyroptosis. Encapsulation of TAPP into redox‐responsive poly (carboxybetaine methacrylate) (PCBMA) nanogels prolongs circulation, enhances passive targeting, and preserves photodynamic activity. In vitro, PCBMA‐TAPP rapidly induces plasma membrane disruption, release of lactate dehydrogenase and adenosine triphosphate, and activation of the NLRP3 inflammasome, thereby promoting dendritic cell maturation. In EMT6 tumor‐bearing mice, PCBMA‐TAPP achieves 84.9% tumor growth inhibition, accompanied by elevated infiltration of CD8 + , CD4 + , and granzyme B expression, without observable systemic toxicity. These findings established a nanoplatform that synergizes organelle‐specific Type I PDT with pyroptosis‐driven immune activation, advancing a clinically translatable strategy for immunotherapy of hypoxic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Engineering of Polymers and Department of Macromolecular Science, Fudan University, Shanghai, P. R. China.
- Institute for Translational Brain Research, MOE Frontiers Center For Brain Science, Fudan University, Shanghai, P. R. China.
ORCID-Profile: Wuli Yang
Förderung
- National Natural Science Foundation of China
- Open Project of State Key Laboratory of Molecular Engineering of Polymers
Zitieren
APA
Diao, Z., Yao, X., Zhang, J., Huang, Y., Guan, X., Peng, H., & Yang, W. (2026). Zwitterionic Photosensitizer Triggers Photopyroptosis for Effective Cancer Immunotherapy. Advanced Healthcare Materials, 15(12). https://doi.org/10.1002/adhm.202503451
Vancouver
Diao Z, Yao X, Zhang J, Huang Y, Guan X, Peng H, et al. Zwitterionic Photosensitizer Triggers Photopyroptosis for Effective Cancer Immunotherapy. Advanced Healthcare Materials. 2026;15(12). doi:10.1002/adhm.202503451
BibTeX
@article{Diao2026,
author = {Diao, Zhuofan and Yao, Xianxian and Zhang, Jiaxin and Huang, Yuxin and Guan, Xinyu and Peng, Haibao and Yang, Wuli},
title = {Zwitterionic Photosensitizer Triggers Photopyroptosis for Effective Cancer Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {12},
doi = {10.1002/adhm.202503451}
}
EUVIMED